Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

VREX vs XRAY vs NNOX vs ATEC vs HOLX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VREX
Varex Imaging Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$496M
5Y Perf.-29.1%
XRAY
DENTSPLY SIRONA Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$2.20B
5Y Perf.-79.1%
NNOX
Nano-X Imaging Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$115M
5Y Perf.-96.1%
ATEC
Alphatec Holdings, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$1.17B
5Y Perf.-46.6%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+3.8%

VREX vs XRAY vs NNOX vs ATEC vs HOLX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VREX logoVREX
XRAY logoXRAY
NNOX logoNNOX
ATEC logoATEC
HOLX logoHOLX
IndustryMedical - DevicesMedical - Instruments & SuppliesMedical - DevicesMedical - DevicesMedical - Instruments & Supplies
Market Cap$496M$2.20B$115M$1.17B$16.97B
Revenue (TTM)$858M$3.68B$12M$595M$4.13B
Net Income (TTM)$-83M$-628M$-56M$-125M$544M
Gross Margin33.6%48.9%-98.8%89.6%52.8%
Operating Margin-3.7%4.1%-469.7%-9.6%17.5%
Forward P/E13.9x7.7x27.1x17.2x
Total Debt$402M$2.47B$7M$620M$2.63B
Cash & Equiv.$145M$326M$39M$161M$1.96B

VREX vs XRAY vs NNOX vs ATEC vs HOLXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VREX
XRAY
NNOX
ATEC
HOLX
StockDec 20May 26Return
Varex Imaging Corpo… (VREX)10070.9-29.1%
DENTSPLY SIRONA Inc. (XRAY)10020.9-79.1%
Nano-X Imaging Ltd. (NNOX)1003.9-96.1%
Alphatec Holdings, … (ATEC)10053.4-46.6%
Hologic, Inc. (HOLX)100103.8+3.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: VREX vs XRAY vs NNOX vs ATEC vs HOLX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HOLX leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. DENTSPLY SIRONA Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. VREX and ATEC also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
VREX
Varex Imaging Corporation
The Momentum Pick

VREX ranks third and is worth considering specifically for momentum.

  • +44.8% vs NNOX's -64.4%
Best for: momentum
XRAY
DENTSPLY SIRONA Inc.
The Value Play

XRAY is the #2 pick in this set and the best alternative if value and dividends is your priority.

  • Lower P/E (7.7x vs 27.1x)
  • 5.9% yield; 23-year raise streak; the other 4 pay no meaningful dividend
Best for: value and dividends
NNOX
Nano-X Imaging Ltd.
The Growth Play

NNOX is the clearest fit if your priority is growth exposure.

  • Rev growth 13.9%, EPS growth 15.7%, 3Y rev CAGR 105.3%
Best for: growth exposure
ATEC
Alphatec Holdings, Inc.
The Long-Run Compounder

ATEC is the clearest fit if your priority is long-term compounding.

  • 225.4% 10Y total return vs HOLX's 124.3%
  • 25.0% revenue growth vs XRAY's -3.0%
Best for: long-term compounding
HOLX
Hologic, Inc.
The Income Pick

HOLX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • beta 0.41
  • Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
  • Beta 0.41, current ratio 3.75x
  • 13.2% margin vs NNOX's -452.8%
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthATEC logoATEC25.0% revenue growth vs XRAY's -3.0%
ValueXRAY logoXRAYLower P/E (7.7x vs 27.1x)
Quality / MarginsHOLX logoHOLX13.2% margin vs NNOX's -452.8%
Stability / SafetyHOLX logoHOLXBeta 0.41 vs VREX's 1.87, lower leverage
DividendsXRAY logoXRAY5.9% yield; 23-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)VREX logoVREX+44.8% vs NNOX's -64.4%
Efficiency (ROA)HOLX logoHOLX6.1% ROA vs NNOX's -31.6%, ROIC 9.4% vs -27.9%

VREX vs XRAY vs NNOX vs ATEC vs HOLX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VREXVarex Imaging Corporation
FY 2024
Medical Segment
71.7%$582M
Industrial Segment
28.3%$229M
XRAYDENTSPLY SIRONA Inc.
FY 2022
Technologies And Equipment
59.1%$2.3B
Consumables Segment
40.9%$1.6B
NNOXNano-X Imaging Ltd.

Segment breakdown not available.

ATECAlphatec Holdings, Inc.
FY 2025
Products And Services
100.0%$764M
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M

VREX vs XRAY vs NNOX vs ATEC vs HOLX — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHOLXLAGGINGATEC

Income & Cash Flow (Last 12 Months)

HOLX leads this category, winning 3 of 6 comparable metrics.

HOLX is the larger business by revenue, generating $4.1B annually — 335.4x NNOX's $12M. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, NNOX holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
RevenueTrailing 12 months$858M$3.7B$12M$595M$4.1B
EBITDAEarnings before interest/tax-$18M$424M-$46M$4M$974M
Net IncomeAfter-tax profit-$83M-$628M-$56M-$125M$544M
Free Cash FlowCash after capex-$31M$104M-$47M$7M$1000M
Gross MarginGross profit ÷ Revenue+33.6%+48.9%-98.8%+89.6%+52.8%
Operating MarginEBIT ÷ Revenue-3.7%+4.1%-4.7%-9.6%+17.5%
Net MarginNet income ÷ Revenue-9.6%-17.1%-4.5%-21.1%+13.2%
FCF MarginFCF ÷ Revenue-3.6%+2.8%-3.8%+1.2%+24.2%
Rev. Growth (YoY)Latest quarter vs prior year+1.5%+0.1%+13.7%-100.0%+2.5%
EPS Growth (YoY)Latest quarter vs prior year-2.5%-150.0%+8.7%+37.1%-9.2%
HOLX leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

XRAY leads this category, winning 2 of 6 comparable metrics.

On an enterprise value basis, XRAY's 7.2x EV/EBITDA is more attractive than ATEC's 3752.1x.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
Market CapShares × price$496M$2.2B$115M$1.2B$17.0B
Enterprise ValueMkt cap + debt − cash$753M$4.3B$83M$1.6B$17.6B
Trailing P/EPrice ÷ TTM EPS-6.96x-3.65x-1.93x-8.07x30.53x
Forward P/EPrice ÷ next-FY EPS est.13.92x7.68x27.09x17.21x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.18x3752.09x17.39x
Price / SalesMarket cap ÷ Revenue0.59x0.60x10.20x1.54x4.14x
Price / BookPrice ÷ Book value/share1.01x1.63x0.55x32.28x3.43x
Price / FCFMarket cap ÷ FCF26.38x21.11x422.56x18.44x
XRAY leads this category, winning 2 of 6 comparable metrics.

Profitability & Efficiency

HOLX leads this category, winning 6 of 9 comparable metrics.

HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-4 for ATEC. NNOX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATEC's 17.21x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs NNOX's 4/9, reflecting strong financial health.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
ROE (TTM)Return on equity-17.1%-41.2%-35.5%-4.4%+11.0%
ROA (TTM)Return on assets-7.6%-11.2%-31.6%-15.8%+6.1%
ROICReturn on invested capital-2.6%+5.1%-27.9%-12.6%+9.4%
ROCEReturn on capital employed-2.9%+6.1%-28.4%-13.7%+8.8%
Piotroski ScoreFundamental quality 0–966467
Debt / EquityFinancial leverage0.83x1.84x0.04x17.21x0.52x
Net DebtTotal debt minus cash$257M$2.1B-$32M$459M$667M
Cash & Equiv.Liquid assets$145M$326M$39M$161M$2.0B
Total DebtShort + long-term debt$402M$2.5B$7M$620M$2.6B
Interest CoverageEBIT ÷ Interest expense-4.94x-5.12x-379.29x-3.29x8.00x
HOLX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HOLX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HOLX five years ago would be worth $11,582 today (with dividends reinvested), compared to $605 for NNOX. Over the past 12 months, VREX leads with a +44.8% total return vs NNOX's -64.4%. The 3-year compound annual growth rate (CAGR) favors HOLX at -2.9% vs NNOX's -52.4% — a key indicator of consistent wealth creation.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
YTD ReturnYear-to-date+1.5%-2.8%-37.8%-62.7%+1.9%
1-Year ReturnPast 12 months+44.8%-16.4%-64.4%-37.8%+37.1%
3-Year ReturnCumulative with dividends-46.3%-69.4%-89.2%-47.8%-8.5%
5-Year ReturnCumulative with dividends-51.8%-80.1%-93.9%-48.7%+15.8%
10-Year ReturnCumulative with dividends-58.0%-74.5%-96.1%+225.4%+124.3%
CAGR (3Y)Annualised 3-year return-18.7%-32.6%-52.4%-19.5%-2.9%
HOLX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

HOLX leads this category, winning 2 of 2 comparable metrics.

HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than VREX's 1.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs NNOX's 30.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
Beta (5Y)Sensitivity to S&P 5001.87x1.78x1.86x1.13x0.41x
52-Week HighHighest price in past year$14.56$17.18$5.86$23.29$76.04
52-Week LowLowest price in past year$6.76$9.85$1.66$6.85$52.81
% of 52W HighCurrent price vs 52-week peak+81.2%+63.8%+30.0%+33.3%+100.0%
RSI (14)Momentum oscillator 0–10056.639.238.526.869.1
Avg Volume (50D)Average daily shares traded261K4.2M1.4M3.0M10.0M
HOLX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: VREX as "Buy", XRAY as "Hold", NNOX as "Buy", ATEC as "Buy", HOLX as "Hold". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 3.9% for HOLX (target: $79). XRAY is the only dividend payer here at 5.86% yield — a key consideration for income-focused portfolios.

MetricVREX logoVREXVarex Imaging Cor…XRAY logoXRAYDENTSPLY SIRONA I…NNOX logoNNOXNano-X Imaging Lt…ATEC logoATECAlphatec Holdings…HOLX logoHOLXHologic, Inc.
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyHold
Price TargetConsensus 12-month target$14.50$13.40$18.00$25.00$79.00
# AnalystsCovering analysts63151642
Dividend YieldAnnual dividend ÷ price+5.9%
Dividend StreakConsecutive years of raises23
Dividend / ShareAnnual DPS$0.64
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%+4.4%
Insufficient data to determine a leader in this category.
Key Takeaway

HOLX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XRAY leads in 1 (Valuation Metrics).

Best OverallHologic, Inc. (HOLX)Leads 4 of 6 categories
Loading custom metrics...

VREX vs XRAY vs NNOX vs ATEC vs HOLX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VREX or XRAY or NNOX or ATEC or HOLX a better buy right now?

For growth investors, Alphatec Holdings, Inc.

(ATEC) is the stronger pick with 25. 0% revenue growth year-over-year, versus -3. 0% for DENTSPLY SIRONA Inc. (XRAY). Hologic, Inc. (HOLX) offers the better valuation at 30. 5x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate Varex Imaging Corporation (VREX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VREX or XRAY or NNOX or ATEC or HOLX?

On forward P/E, DENTSPLY SIRONA Inc.

is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — VREX or XRAY or NNOX or ATEC or HOLX?

Over the past 5 years, Hologic, Inc.

(HOLX) delivered a total return of +15. 8%, compared to -93. 9% for Nano-X Imaging Ltd. (NNOX). Over 10 years, the gap is even starker: ATEC returned +225. 4% versus NNOX's -96. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VREX or XRAY or NNOX or ATEC or HOLX?

By beta (market sensitivity over 5 years), Hologic, Inc.

(HOLX) is the lower-risk stock at 0. 41β versus Varex Imaging Corporation's 1. 87β — meaning VREX is approximately 356% more volatile than HOLX relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VREX or XRAY or NNOX or ATEC or HOLX?

By revenue growth (latest reported year), Alphatec Holdings, Inc.

(ATEC) is pulling ahead at 25. 0% versus -3. 0% for DENTSPLY SIRONA Inc. (XRAY). On earnings-per-share growth, the picture is similar: DENTSPLY SIRONA Inc. grew EPS 33. 0% year-over-year, compared to -45. 3% for Varex Imaging Corporation. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VREX or XRAY or NNOX or ATEC or HOLX?

Hologic, Inc.

(HOLX) is the more profitable company, earning 13. 8% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — ATEC leads at 69. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VREX or XRAY or NNOX or ATEC or HOLX more undervalued right now?

On forward earnings alone, DENTSPLY SIRONA Inc.

(XRAY) trades at 7. 7x forward P/E versus 27. 1x for Alphatec Holdings, Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NNOX: 922. 7% to $18. 00.

08

Which pays a better dividend — VREX or XRAY or NNOX or ATEC or HOLX?

In this comparison, XRAY (5.

9% yield) pays a dividend. VREX, NNOX, ATEC, HOLX do not pay a meaningful dividend and should not be held primarily for income.

09

Is VREX or XRAY or NNOX or ATEC or HOLX better for a retirement portfolio?

For long-horizon retirement investors, Hologic, Inc.

(HOLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +124. 3% 10Y return). Nano-X Imaging Ltd. (NNOX) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOLX: +124. 3%, NNOX: -96. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VREX and XRAY and NNOX and ATEC and HOLX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: VREX is a small-cap quality compounder stock; XRAY is a small-cap income-oriented stock; NNOX is a small-cap quality compounder stock; ATEC is a small-cap high-growth stock; HOLX is a mid-cap quality compounder stock. XRAY pays a dividend while VREX, NNOX, ATEC, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

VREX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
Run This Screen
Stocks Like

XRAY

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 29%
  • Dividend Yield > 2.3%
Run This Screen
Stocks Like

NNOX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
Run This Screen
Stocks Like

ATEC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 53%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VREX and XRAY and NNOX and ATEC and HOLX on the metrics below

Revenue Growth>
%
(VREX: 1.5% · XRAY: 0.1%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.